Spark Therapeutics Inc (272) is traded on Frankfurt Stock Exchange in Germany. and employs 27 people. The company currently falls under 'Mid-Cap
' category with current market capitalization of 1.76 B. Spark Therapeutics Inc has 36.93 M outstanding shares.
SPARK THERAPEUTICS has accumulated about 478.7 M in cash with (156.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.94.
Check Spark Therapeutics Probability Of Bankruptcy